Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.23 USD | +15.25% | +32.74% | +95.61% |
Mar. 21 | NextCure, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 20 | North American Morning Briefing : Markets on Hold -2- | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 62.22M |
---|---|---|---|---|---|
Net income 2024 * | -46M | Net income 2025 * | -50M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.34
x | P/E ratio 2025 * |
-1.32
x | Employees | 82 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.12% |
1 day | +15.25% | ||
1 week | +32.74% | ||
Current month | +28.90% | ||
1 month | +39.38% | ||
3 months | +93.91% | ||
6 months | +72.87% | ||
Current year | +95.61% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Richman
FOU | Founder | 63 | 15-11-30 |
Steven Cobourn
DFI | Director of Finance/CFO | 61 | 17-12-31 |
Han Myint
CTO | Chief Tech/Sci/R&D Officer | 71 | 21-01-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Kabakoff
CHM | Chairman | 76 | 15-11-30 |
Michael Richman
FOU | Founder | 63 | 15-11-30 |
Chau Khuong
BRD | Director/Board Member | 48 | 15-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.23 | +15.25% | 1,018,516 |
24-03-27 | 1.935 | -1.78% | 112,790 |
24-03-26 | 1.97 | -1.01% | 301,294 |
24-03-25 | 1.99 | +4.74% | 377,792 |
24-03-22 | 1.9 | +13.10% | 1,019,015 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+95.61% | 62.22M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |